Advanced Oncotherapy raises £5.9m to progress LIGHT system

Advanced Oncotherapy CEO Nicolas Serandour

Proton beam therapy specialist Advanced Oncotherapy (AVO) has raised £5.9m through a placing and subscription for 14.8m shares at 40p per share. The move follows a £7.7m fundraise in October and will be used to progress the company’s next generation proton beam therapy system, LIGHT, which is due to become operational later this year. The placing was…

You must be a HM Subscriber to view this content.

Subscribe Now »